PAM
NUVB icon

Panagora Asset Management’s Nuvation Bio NUVB Stock Holding History

Panagora Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-341,763
Closed -$909K – 1169
2024
Q4 		$909K Sell
341,763
-263,709
-44% -$679K ﹤0.01% 677
2024
Q3 		$1.39M Sell
605,472
-28,204
-4% -$86K 0.01% 628
2024
Q2 		$1.85M Buy
633,676
+421,563
+199% +$1.29M 0.01% 545
2024
Q1 		$772K Buy
+212,113
New +$407K ﹤0.01% 874

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Panagora Asset Management's NUVB Position: Q1 2025 in Review

Panagora Asset Management sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 341,763 shares — an estimated $909K sold.

Panagora Asset Management first reported a position in NUVB in Q1 2024 and held it in 4 quarters. The position peaked at $1.85M in Q2 2024. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Panagora Asset Management reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
  • Panagora Asset Management sold 341,763 Nuvation Bio shares in Q1 2025, an estimated $909K.
  • Panagora Asset Management first reported a position in Nuvation Bio in Q1 2024 and held it in 4 quarters.
  • Panagora Asset Management's Nuvation Bio position peaked at $1.85M in Q2 2024.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Panagora Asset Management's 13F filing for Q1 2025, filed 15 May 2025.